Transplant-associated thrombotic microangiopathy:a rare but deadly complication post orthotopic heart transplantation  

作　　者：Jose Ruiz-Morales Maedeh Ganji Rohan Goswami 

机构地区：[1]Division of Advanced Heart Failure&Transplant Cardiology,Mayo Clinic,Jacksonville,Florida,USA [2]Cardiology Department,University of Florida,Jacksonville,Florida,USA

出　　处：《Journal of Geriatric Cardiology》2022年第6期485-486,共2页老年心脏病学杂志（英文版）

摘　　要：Thrombotic microangiopathy(TMA)is potentially life-threatening condition caused by small-vessel microthrombi and is associated with schistocyte formation,low platelets and end-organ damage that may not be reversible.[1,2]As a life-threatening condition,TMA recognition in hospitalized patients after organ transplantation is key to improving survival.Transplant-associated TMA(TATMA)can occur after both solid organ or hematopoietic stem cell transplantation and often mimics other disease processes such as thrombotic throm-bocytopenic purpura(TTP)with similar constellation of symptoms during presentation.We present a rare case of a patient with TATMA after orthotopic heart transplantation.

关 键 词：THROMBOTIC MICROANGIOPATHY ORTHOTOPIC 

分 类 号：R654.2[医药卫生—外科学]